Skip to main content

Table 4 Comparison of hematological outcomes

From: Safety, efficacy, and cost-effectiveness of intraoperative blood salvage in OPCABG with different amount of bleeding: a single-center, retrospective study

Indexes Group N Pre-surgery 1 d post-surgery 2 d post-surgery 7 d post-surgery
HGB(g/L) IBS1 34 126.41 ± 12.03 123.41 ± 15.51 119.24 ± 16.86 124.65 ± 19.05
AB1 67 127.57 ± 11.38 124.90 ± 12.48 119.24 ± 12.30 127.81 ± 73.53
IBS2 44 131.43 ± 11.78 123.86 ± 13.98 118.55 ± 17.12 125.30 ± 17.25
AB2 70 129.97 ± 13.09 124.57 ± 13.21 120.11 ± 14.66 130.17 ± 16.72
IBS3 50 134.54 ± 13.16 115.62 ± 19.41 113.22 ± 14.18 126.18 ± 14.13
AB3 56 137.14 ± 13.07 118.71 ± 13.02 116.91 ± 15.12 129.32 ± 16.03
WBC(109/L) IBS1 34 6.39 ± 1.43 14.43 ± 4.00 13.99 ± 4.54 8.99 ± 2.42
AB1 67 6.18 ± 1.64 13.98 ± 3.67 12.98 ± 4.29 9.62 ± 2.62
IBS2 44 6.59 ± 1.49 15.52 ± 4.43 14.54 ± 3.70 9.45 ± 2.83
AB2 70 6.73 ± 1.57 14.52 ± 3.59 13.17 ± 4.66 9.97 ± 2.82
IBS3 50 6.62 ± 1.76 14.06 ± 3.92 15.08 ± 5.07b 10.63 ± 4.45
AB3 56 6.83 ± 1.78 13.53 ± 3.55 12.53 ± 3.53 9.79 ± 2.77
RBC(1012/L) IBS1 34 4.17 ± 0.53 4.06 ± 0.44 3.91 ± 0.50 4.11 ± 0.55
AB1 67 4.23 ± 0.38 4.16 ± 0.41 3.94 ± 0.43 4.20 ± 0.53
IBS2 44 4.29 ± 0.48 4.07 ± 0.48 3.87 ± 0.56 4.19 ± 0.64
AB2 70 4.30 ± 0.45 4.08 ± 0.39 3.92 ± 0.47 4.21 ± 0.53
IBS3 50 4.36 ± 0.45 3.80 ± 0.39 3.56 ± 0.39 4.10 ± 0.41
AB3 56 4.51 ± 0.41 3.97 ± 0.43 3.65 ± 0.51 4.18 ± 0.60
PLT(109/L) IBS1 34 200.15 ± 65.35 191.68 ± 72.16 152.76 ± 58.65 209.12 ± 65.99
AB1 67 213.25 ± 65.21 167.84 ± 55.63 135.76 ± 73.53 203.24 ± 73.53
IBS2 44 212.45 ± 57.45 184.39 ± 61.64 156.68 ± 69.92 212.30 ± 97.22
AB2 70 219.91 ± 71.88 184.43 ± 55.13 150.47 ± 54.44 220.09 ± 80.20
IBS3 50 212.26 ± 50.83 172.58 ± 57.43 142.82 ± 52.47 236.44 ± 97.12
AB3 56 208.68 ± 61.78 156.20 ± 38.59 137.63 ± 47.12 213.23 ± 91.22
  1. HGB hemoglobin, WBC white blood cell count, RBC red blood cell count, PLT platelet
  2. bP < 0.01 vs. AB group